TRIMTECH Therapeutics

TRIMTECH Therapeutics' mission is to create novel, highly differentiated, orally active small-molecule degraders of protein aggregates to combat major neurodegenerative and inflammatory diseases with significant medical needs. The company's platform offers oral therapeutic drugs with specificity for aggregated proteins, ensuring safety and the potential for personalized treatment approaches targeting neurological, inflammatory, and oncological diseases, enabling patients to access effective and safe treatment options.